Anixa Biosciences, Inc.
General ticker "ANIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $100.6M (TTM average)
Anixa Biosciences, Inc. follows the US Stock Market performance with the rate: 48.2%.
Estimated limits based on current volatility of 2.6%: low 3.14$, high 3.35$
Factors to consider:
- Total employees count: 5 (0.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: History of losses, Need for additional capital, Rapid resource consumption, Operational and conduct risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 12 months up through Q4 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-10-31 to 2026-10-31
- 2024-10-31 to 2025-10-31 estimated range: [2.18$, 4.84$]
- 2025-10-31 to 2026-10-31 estimated range: [2.33$, 5.13$]
Financial Metrics affecting the ANIX estimates:
- Positive: with PPE of -8.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.83 <= 0.04
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 3.98 > -0.62
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 92.62 > 64.17
Short-term ANIX quotes
Long-term ANIX plot with estimates
Financial data
| YTD | 2022-10-31 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.21MM | $0.00MM |
| Operating Expenses | $13.88MM | $11.22MM | $13.83MM |
| Operating Income | $-13.88MM | $-11.01MM | $-13.83MM |
| Non-Operating Income | $0.10MM | $1.08MM | $1.13MM |
| R&D Expense | $6.70MM | $4.77MM | $6.40MM |
| Income(Loss) | $-13.77MM | $-9.93MM | $-12.70MM |
| Profit(Loss)* | $-13.60MM | $-9.81MM | $-12.55MM |
| Stockholders Equity | $29.05MM | $24.34MM | $20.00MM |
| Inventory | $0.05MM | $0.00MM | $0.00MM |
| Assets | $30.41MM | $25.52MM | $21.59MM |
| Operating Cash Flow | $-6.49MM | $-6.21MM | $-7.33MM |
| Investing Cash Flow | $-10.73MM | $-5.60MM | $4.28MM |
| Financing Cash Flow | $0.45MM | $0.37MM | $3.42MM |
| Earnings Per Share** | $-0.45 | $-0.32 | $-0.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.